HTB South

Dolutegravir use in pregnancy: results from small Belgian cohort

Polly Clayden, HIV i-Base

There were no vertical transmissions, obstetrical complications or birth defects among 11 dolutegravir (DTG)-exposed pregnancies at a Brussels-based centre between November 2015 and June 2017.

Preliminary data from a prospective observational study of pregnant women and their children exposed to DTG at Hôpital Erasme were presented at EACS 2017.

Full report at this link.

Links to other websites are current at date of posting but not maintained.